Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 11/20 | 0.65 |
| ▸ | NPY1R | P25929 | 1/20 | 0.62 |
| ▸ | NPY2R | P49146 | 1/20 | 0.62 |
| ▸ | NPY4R | P50391 | 1/20 | 0.62 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.62 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.61 |
| ▸ | IL23R | Q5VWK5 | 5/20 | 0.60 |
| ▸ | MC4R | P32245 | 1/20 | 0.56 |
| ▸ | MC5R | P33032 | 1/20 | 0.56 |
| ▸ | MC3R | P41968 | 1/20 | 0.56 |
| ▸ | MC1R | Q01726 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30527936 | 1.00 | CXCR4 (0.65) | CXCR4NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL29416084 | 0.96 | NPY1R (0.65) | CXCR4NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL29416134 | 0.90 | C5AR1 (0.64) | CXCR4NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL29618035 | 0.89 | CXCR4 (0.72) | CXCR4NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL29672871 | 0.89 | IL23R (0.70) | CXCR4NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL31622299 | 0.88 | CXCR4 (0.66) | CXCR4NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL31707333 | 0.88 | CXCR4 (0.73) | CXCR4NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL31182522 | 0.88 | NPY2R (0.71) | CXCR4NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL31452905 | 0.87 | CXCR4 (0.62) | CXCR4C5AR1IL23R | |
| SCHEMBL31622296 | 0.87 | C5AR1 (0.71) | CXCR4NPY1RNPY2RNPY4RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110381984-B | Compositions and methods for improving sexual function | 尼莫克斯股份有限公司 | 2023-11-28 | — | — | CN | disclosed |
| EP-4275688-A2 | METHOD OF AMELIORATING OR PREVENTING THE WORSENING OR THE PROGRESSION OF SYMPTOMS OF BPH | Nymox Corporation (BS) | 2023-11-15 | — | — | EP | disclosed |
| CN-114099636-A | Method of treating a condition requiring cell destruction or removal using peptides derived from neurofilament proteins | 尼莫克斯制药公司 | 2022-03-01 | — | — | CN | disclosed |